Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JANX Janux Therapeutics, Inc.

交易中 12-15 12:09:45 EST

14.99

-0.31

-2.03%

最高15.58	最低14.96	成交量81.13万
今开15.55	昨收15.30	日振幅4.05%
总市值9.02亿	流通市值6.74亿	总股本6,015万
成交额1,234万	换手率1.80%	流通股本4,497万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JANX","market":"US","secType":"STK","nameCN":"Janux Therapeutics, Inc.","latestPrice":14.99,"timestamp":1765818579475,"preClose":15.3,"halted":0,"volume":811309,"delay":0,"floatShares":44966949,"shares":60147807,"eps":-1.680221,"marketStatus":"交易中","change":-0.31,"latestTime":"12-15 12:09:45 EST","open":15.55,"high":15.58,"low":14.96,"amount":12342159.85885,"amplitude":0.040523,"askPrice":15,"askSize":796,"bidPrice":14.97,"bidSize":568,"shortable":3,"etf":0,"ttmEps":-1.680221,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1623384000000,"exchange":"NASDAQ","adjPreClose":15.3,"preHourTrading":{"tag":"盘前","latestPrice":15.5,"preClose":15.3,"latestTime":"09:28 EST","volume":1237,"amount":19109.100543,"timestamp":1765808880018},"postHourTrading":{"tag":"盘后","latestPrice":15.49,"preClose":15.3,"latestTime":"19:44 EST","volume":227074,"amount":3473781.1022,"timestamp":1765586699242},"volumeRatio":0.997244,"impliedVol":0.6468,"impliedVolPercentile":0.06},"requestUrl":"/m/hq/s/JANX/wiki","defaultTab":"wiki","newsList":[{"id":"1136546380","title":"Janux Therapeutics股价在盘前交易中下跌44.3%，因公司公布早期前列腺癌药物临床试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1136546380","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136546380?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:26","pubTimestamp":1764667569,"startTime":"0","endTime":"0","summary":"Janux Therapeutics股价在盘前交易中下跌44.3%，因公司公布早期前列腺癌药物临床试验数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JANX"],"gpt_icon":0},{"id":"1159090029","title":"Janux公布在转移性去势抵抗性前列腺癌的I期临床试验中令人鼓舞的疗效和安全性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1159090029","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159090029?lang=zh_cn&edition=full","pubTime":"2025-12-02 05:06","pubTimestamp":1764623171,"startTime":"0","endTime":"0","summary":"Janux公布在转移性去势抵抗性前列腺癌的I期临床试验中令人鼓舞的疗效和安全性数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JANX","BK4539","BK4139"],"gpt_icon":0},{"id":"2568413922","title":"Janux Therapeutics, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568413922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568413922?lang=zh_cn&edition=full","pubTime":"2025-09-17 22:09","pubTimestamp":1758118150,"startTime":"0","endTime":"0","summary":"北京时间2025年09月17日22时09分，Janux Therapeutics, Inc.股票出现波动，股价急速上涨5.04%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Scisparc Ltd.、Cdt Equity Inc.、Cdt Equity Inc C/Wts 22/09/2028涨幅较大，Scisparc Ltd.、Cdt Equity Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5243.09%、3965.93%、263.80%，振幅较大的相关个股有Scisparc Ltd.、Cdt Equity Inc.、Vyome Holdings, Inc.，振幅分别为147.28%、39.76%、38.21%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917220910a4cbd4ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917220910a4cbd4ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","JANX","LENZ"],"gpt_icon":0},{"id":"2561413052","title":"Janux Therapeutics, Inc.盘中异动 股价大跌5.31%报23.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561413052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561413052?lang=zh_cn&edition=full","pubTime":"2025-08-22 00:09","pubTimestamp":1755792562,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日00时09分，Janux Therapeutics, Inc.股票出现波动，股价大幅下跌5.31%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、知临集团、Protagenic Therapeutics, Inc.涨幅较大，Protagenic Therapeutics, Inc.、知临集团、Tharimmune, Inc.较为活跃，换手率分别为15323.31%、3669.42%、1369.89%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、知临集团，振幅分别为459.84%、116.23%、113.39%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，开发针对癌症的肿瘤激活免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822000923a6f3b78a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822000923a6f3b78a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","JANX","BK4007","BK4539"],"gpt_icon":0},{"id":"2517430499","title":"Janux Therapeutics, Inc.2024财年实现净利润-68.99百万美元，同比减少18.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430499?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363252,"startTime":"0","endTime":"0","summary":"3月8日，Janux Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-68.99百万美元，同比减少18.36%；其中营业收入为10.59百万美元，同比增加31.06%，每股基本收益为-1.28美元。从资产负债表来看，Janux Therapeutics, Inc.总负债38.74百万美元，其中短期债务1.75百万美元，资产负债比为0.28，流动比率为0.60。机构评级：截至2025年3月8日，当前有13家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为86.54美元，其中最低目标价为25.00美元，最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000225abed6693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000225abed6693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX"],"gpt_icon":0},{"id":"2517694882","title":"Janux Therapeutics, Inc.盘中异动 早盘急速拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517694882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517694882?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:39","pubTimestamp":1741185583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时39分，Janux Therapeutics, Inc.股票出现波动，股价急速上涨5.47%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223944a260ca65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223944a260ca65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JANX","LENZ","BK4139"],"gpt_icon":0},{"id":"2516589677","title":"Janux Therapeutics, Inc.盘中异动 早盘大幅跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516589677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516589677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098719,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Janux Therapeutics, Inc.股票出现异动，股价大幅跳水5.28%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223159a25f0476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223159a25f0476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","JANX"],"gpt_icon":0},{"id":"2516585562","title":"Scotiabank：维持Janux Therapeutics(JANX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由62.00美元调整至41.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516585562","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516585562?lang=zh_cn&edition=full","pubTime":"2025-03-01 07:47","pubTimestamp":1740786423,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Janux Therapeutics(JANX.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由62.00美元调整至41.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01074748470501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["JANX","LENZ"],"gpt_icon":0},{"id":"1136124682","title":"Janux Therapeutics 2024年第四季度GAAP每股收益$(0.36) 超出预期$(0.47)","url":"https://stock-news.laohu8.com/highlight/detail?id=1136124682","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136124682?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:38","pubTimestamp":1740692305,"startTime":"0","endTime":"0","summary":"Janux Therapeutics  报告季度每股亏损$，超出分析师一致预期的$，超过23.4%。相比去年同期每股亏损$，这是一个44%的下降。以上内容来自Benzinga Earnings专栏，原文如下：Janux $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 23.4 percent. This is a 44 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","JANX"],"gpt_icon":0},{"id":"2513576720","title":"Janux Therapeutics, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513576720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513576720?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:54","pubTimestamp":1740408845,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时54分，Janux Therapeutics, Inc.股票出现波动，股价大幅下跌5.03%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为136.18%、55.56%、25.06%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225406962e9e7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225406962e9e7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","JANX","LENZ"],"gpt_icon":0},{"id":"2509238049","title":"Janux Therapeutics, Inc.盘中异动 早盘急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509238049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509238049?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:44","pubTimestamp":1738770244,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时44分，Janux Therapeutics, Inc.股票出现异动，股价急速拉升5.06%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.45%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4054.20%、1197.54%、978.89%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205234405abc38da0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205234405abc38da0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX","BK4139","BK4539"],"gpt_icon":0},{"id":"2508835463","title":"Janux Therapeutics, Inc.盘中异动 早盘股价大跌5.25%报39.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508835463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508835463?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:23","pubTimestamp":1738682607,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时23分，Janux Therapeutics, Inc.股票出现异动，股价大幅下挫5.25%。截至发稿，该股报39.86美元/股，成交量20.2631万股，换手率0.35%，振幅5.35%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204232327abc232e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204232327abc232e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","JANX","BK4139"],"gpt_icon":0},{"id":"2506874303","title":"Janux Therapeutics, Inc.盘中异动 早盘股价大涨5.10%报46.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506874303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506874303?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:42","pubTimestamp":1737988923,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时42分，Janux Therapeutics, Inc.股票出现波动，股价大幅拉升5.10%。截至发稿，该股报46.36美元/股，成交量3.2984万股，换手率0.06%，振幅6.78%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224203a2316d37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127224203a2316d37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"1143280520","title":"异动解读 | 生物技术公司Janux Therapeutics盘中大跌5.26%,最新财报不佳或成主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1143280520","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143280520?lang=zh_cn&edition=full","pubTime":"2025-01-17 02:34","pubTimestamp":1737052472,"startTime":"0","endTime":"0","summary":"生物技术公司Janux Therapeutics(JANX.us)今日盘中大跌5.26%,引发投资者广泛关注。根据最新财报数据,该公司净利润亏损达2806万美元,每股收益为-0.51美元,可能是导致股价下跌的主要因素之一。\n\n此外,整个生物技术行业当日呈现整体下跌态势,跌幅达0.35%,为Janux Therapeutics股价下跌增添了一些压力。不过,目前仍无其他直接相关消息可解释该股今日出现如此大幅波动。\n\n市场机构方面,在16家参与评级的分析机构中,高达88%给予该股买入评级,看好其长期发展前景。后市如何走向或将取决于公司未来的基本面表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 生物技术公司Janux Therapeutics盘中大跌5.26%,最新财报不佳或成主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["JANX"],"gpt_icon":0},{"id":"2504946519","title":"Janux Therapeutics, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504946519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504946519?lang=zh_cn&edition=full","pubTime":"2025-01-17 02:18","pubTimestamp":1737051514,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日02时18分，Janux Therapeutics, Inc.股票出现波动，股价急速下挫5.08%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117021834960636d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117021834960636d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","JANX","LENZ"],"gpt_icon":0},{"id":"2503758308","title":"Janux Therapeutics, Inc.盘中异动 急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503758308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503758308?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:44","pubTimestamp":1736779470,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时44分，Janux Therapeutics, Inc.股票出现波动，股价快速下挫5.26%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132244309864d883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132244309864d883&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2502867159","title":"Janux Therapeutics, Inc.盘中异动 急速下跌5.14%报48.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502867159?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:50","pubTimestamp":1736520658,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时50分，Janux Therapeutics, Inc.股票出现异动，股价快速下跌5.14%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110225058aba607de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110225058aba607de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JANX","LENZ","BK4139"],"gpt_icon":0},{"id":"2501343773","title":"Janux Therapeutics, Inc.盘中异动 股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501343773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501343773?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:36","pubTimestamp":1736346979,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时36分，Janux Therapeutics, Inc.股票出现异动，股价大幅下挫5.54%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223619a21a5442&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223619a21a5442&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","JANX"],"gpt_icon":0},{"id":"1137546102","title":"盘前异动 | 特斯拉跌1.4%，中国销量同比下滑4%；医药公司Janux涨近60%，其前列腺癌药物获得突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1137546102","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137546102?lang=zh_cn&edition=full","pubTime":"2024-12-03 17:24","pubTimestamp":1733217854,"startTime":"0","endTime":"0","summary":"$超微电脑$ 续涨超8%，公司经审查未发现欺诈证据，隔夜已涨近30%。此前超微电脑在声明中表示，经过公司董事会特别委员会和外部律师的审查后，未发现任何不当行为，安永会计师事务所的辞职及其在辞职信中提到的结论未得到审查支持。生物医药公司 $Janux Therapeutics, Inc.$ 盘前涨近60%，其前列腺癌治疗药物因展现出令人鼓舞的有效性和安全性结果而被选入扩大试验。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"72efd440e6195560f0a519d2a0eb096b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLA","JANX"],"gpt_icon":1},{"id":"2488199608","title":"Janux Therapeutics, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488199608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488199608?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:40","pubTimestamp":1733154004,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时40分，Janux Therapeutics, Inc.股票出现波动，股价快速跳水5.07%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223400598e4ee1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223400598e4ee1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","JANX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.januxrx.com","stockEarnings":[{"period":"1week","weight":-0.0733},{"period":"1month","weight":-0.4635},{"period":"3month","weight":-0.3638},{"period":"6month","weight":-0.3855},{"period":"1year","weight":-0.7512},{"period":"ytd","weight":-0.7142}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Janux Therapeutics, Inc.于2017年6月27日在特拉华州注册成立。该公司是一家创新的生物制药公司，开发基于该公司专有的肿瘤激活T细胞接合器（TRACTr）平台技术的下一代疗法，以更好地治疗癌症患者。该公司最初的重点是开发一类新的T细胞接合器（TCE），该公司的主要候选产品是针对临床验证的药物靶点设计的。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.017049},{"month":2,"riseRate":0.5,"avgChangeRate":1.072919},{"month":3,"riseRate":0,"avgChangeRate":-0.210851},{"month":4,"riseRate":0.75,"avgChangeRate":0.173971},{"month":5,"riseRate":0.25,"avgChangeRate":-0.113738},{"month":6,"riseRate":0.5,"avgChangeRate":-0.031968},{"month":7,"riseRate":0.8,"avgChangeRate":0.101052},{"month":8,"riseRate":0.4,"avgChangeRate":-0.03768},{"month":9,"riseRate":0.4,"avgChangeRate":-0.031046},{"month":10,"riseRate":0.8,"avgChangeRate":0.092219},{"month":11,"riseRate":0.4,"avgChangeRate":-0.026162},{"month":12,"riseRate":0.6,"avgChangeRate":-0.012525}],"exchange":"NASDAQ","name":"Janux Therapeutics, Inc.","nameEN":"Janux Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Janux Therapeutics, Inc.,JANX,Janux Therapeutics, Inc.股票,Janux Therapeutics, Inc.股票老虎,Janux Therapeutics, Inc.股票老虎国际,Janux Therapeutics, Inc.行情,Janux Therapeutics, Inc.股票行情,Janux Therapeutics, Inc.股价,Janux Therapeutics, Inc.股市,Janux Therapeutics, Inc.股票价格,Janux Therapeutics, Inc.股票交易,Janux Therapeutics, Inc.股票购买,Janux Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}